A Novel Micro ECMO (MECMO) Circuit Decreases Bleeding and
Download
Report
Transcript A Novel Micro ECMO (MECMO) Circuit Decreases Bleeding and
A Novel Micro ECMO
(MECMO) Circuit Decreases
Bleeding and Allows for Easier
Transportation
Montefiore Medical Center
The Childrens Hospital at Montefiore
New York, NY 10467
Goals of MECMO Circuit
Decrease surface area
Decrease prime volume
Decrease blood product requirements
Minimize bleeding and thrombosis
Allow for safe transport of circuit
Circuit Revisions
Change in oxygenator
Decreased length and diameter of tubing (1/4 inch to
3/16 inch)
Elimination of components without a biocompatible
surface coating
MECMO Setup
Comparison of ECMO Circuits
72 Hour Blood Product Administration, Bleeding, Heparin Dosing, and Thrombosis
Old ECMO
"Micro ECMO"
(n=3)
(n=3)
Weight (kg)
4.79 ± 2.3
5.87 ± .02
Albumin (mL/kg)
47.69 ± 11.8
7.65 ± 6.62
Red Blood Cells (mL/kg)
83.73 ± 20.18
60.24 ± 19.88
Fresh Frozen Plasma (mL/kg)
12.24 ± 3.24
3.4 ± 5.88
Platelets (mL/kg)
50.13 ± 24.09
44.99 ± 10.3
Cryoprecipitate (mL/kg)
5.14 ± 4.77
0
Total Blood Products (mL/kg)
199.18 ± 38.56
116.27 ± 32.16
Blood Loss (mL/kg)
Total Heparin (units/kg)
Thrombosis Requiring Circuit Change
29.08 ± 12.32
14.2 ± 3.23
251 ± 265
334 ± 291
1
1
Transportation
Conclusions
In patients less than 10kg there was less blood loss
and decreased blood product requirements within
first 72 hours of surgery.
No difference in thrombosis or circuit change
Console can be mounted to patient bed or pole
allowing for easier transport.